STAAR Surgical CEO RSUs vest, shares withheld
STAAR Surgical President and CEO Warren Foust reported the vesting and conversion of 20,787 Restricted Stock Units granted on February 2, 2026 in connection with his appointment as Interim Co-Chief Executive Officer.
Rhea-AI Filing Summary
STAAR Surgical President and CEO Warren Foust reported the vesting and conversion of 20,787 Restricted Stock Units granted on February 2, 2026 in connection with his appointment as Interim Co-Chief Executive Officer. These RSUs vested on July 31, 2026 and converted into common stock on a one-for-one basis. To satisfy obligations associated with this vesting, 10,576 common shares were withheld at $24.36 per share. A footnote also corrects an earlier Form 4, stating his beneficial ownership was 76,345 shares rather than 83,112 in that prior report.
Positive
- None.
Negative
- None.
Insider Trade Summary
20,787 shares exercised/converted
Exercise
3 txns
Insider
Foust Warren
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1 | 20,787 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 20,787 | -- | -- |
| Exercise Price or Tax Liability | Common Stock | 10,576 | $24.36 | $258K |
Holdings After Transaction:
Restricted Stock Units — 0 contracts (Direct);
Common Stock — 86,556 shares (Direct)
Footnotes (2)
- F1. Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on February 2, 2026, in connection with his appointment as Interim Co-Chief Executive Officer of the Issuer on such date. These RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis.
- F2. Due to clerical errors, the Reporting Person's prior Form 4 filed with the Securities and Exchange Commission on May 19, 2026, incorrectly reported this value as 83,112 when the Reporting Person beneficially owned 76,345 shares. The values have been corrected herein.
Key Figures
RSUs vested and converted: 20,787 units
Common shares acquired via RSU conversion: 20,787 shares
Shares withheld to cover obligations: 10,576 shares
+3 more
6 metrics
RSUs vested and converted
20,787 units
Restricted Stock Units vested and converted into common stock on July 31, 2026
Common shares acquired via RSU conversion
20,787 shares
Common Stock received upon one-for-one RSU conversion on July 31, 2026
Shares withheld to cover obligations
10,576 shares
Common shares withheld in a code F transaction related to RSU vesting
Withholding valuation price
$24.36 per share
Per-share value applied to 10,576 withheld shares in the code F transaction
Prior reported ownership (incorrect)
83,112 shares
Incorrect beneficial ownership previously reported in a May 19, 2026 Form 4
Corrected prior ownership
76,345 shares
Actual beneficial ownership for that prior date, as clarified in footnote F2
Key Terms
Restricted Stock Units, beneficially owned, Interim Co-Chief Executive Officer
3 terms
Restricted Stock Units financial
"Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
beneficially owned financial
"incorrectly reported this value as 83,112 when the Reporting Person beneficially owned 76,345 shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Interim Co-Chief Executive Officer financial
"granted to the Reporting Person on February 2, 2026, in connection with his appointment as Interim Co-Chief Executive Officer"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did STAAR Surgical (STAA) CEO Warren Foust report on July 31, 2026?
Warren Foust reported vesting of 20,787 RSUs that converted into common stock and withholding of 10,576 shares. The RSUs were granted on February 2, 2026 in connection with his appointment as Interim Co-Chief Executive Officer and vested on July 31, 2026.
How many RSUs vested for STAAR Surgical (STAA) CEO Warren Foust and when did they vest?
A total of 20,787 Restricted Stock Units vested for Warren Foust on July 31, 2026. These RSUs were originally granted on February 2, 2026 in connection with his appointment as Interim Co-Chief Executive Officer and convert into common stock on a one-for-one basis.
Was a Rule 10b5-1 trading plan used in Warren Foust’s STAAR Surgical (STAA) Form 4 transactions?
The transactions were not identified as being executed under a Rule 10b5-1 trading plan. The Rule 10b5-1 checkbox was not marked as affirming plan use, and no footnote describes the trades as made pursuant to such a pre-arranged plan.
What correction to prior beneficial ownership did STAAR Surgical (STAA) disclose for Warren Foust?
A footnote explains a clerical error in a prior Form 4 that reported 83,112 shares beneficially owned. The corrected figure for that earlier date is 76,345 shares, and the current report states that the values have been corrected accordingly.
AI-generated analysis. How Rhea-AI works. Not financial advice.
